Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the discovery of novel agents for the treatment of glaucoma
Francesco Mincione, Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 10, pp. 1209-1225
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 63
Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Haytham O. Tawfik, Mohamed M. Saleh, Andrea Ammara, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1611-1623
Closed Access | Times Cited: 20
Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2478-2488
Open Access | Times Cited: 48
Multi- and poly-pharmacology of carbonic anhydrase inhibitors
Claudiu T. Supuran
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100004-100004
Closed Access | Times Cited: 10
Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1702-1714
Open Access | Times Cited: 43
Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms
Wagdy M. Eldehna, Mohammed S. Taghour, Tarfah Al‐Warhi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 531-541
Open Access | Times Cited: 29
Drug interactions of carbonic anhydrase inhibitors and activators
Claudiu T. Supuran
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 3, pp. 143-155
Closed Access | Times Cited: 7
Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents
Murat İrkeç, Anastasios G. Konstas, Gábor Holló, et al.
Expert Opinion on Investigational Drugs (2025)
Closed Access
Evaluation of Machine Learning Methods for Identifying Carbonic Anhydrase-II Inhibitors as Drug Candidates for Glaucoma
Teuku Rizky Noviandy, Eva Imelda, Ghazi Mauer Idroes, et al.
Malacca Pharmaceutics (2025) Vol. 3, Iss. 1, pp. 32-41
Closed Access
4-Cyanamidobenzenesulfonamide derivatives: a novel class of human and bacterial carbonic anhydrase inhibitors
Morteza Abdoli, Alessandro Bonardi, Claudiu T. Supuran, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 156-165
Open Access | Times Cited: 15
Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
Zainab M. Elsayed, Hadia Almahli, Alessio Nocentini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
Small Structural Differences Govern the Carbonic Anhydrase II Inhibition Activity of Cytotoxic Triterpene Acetazolamide Conjugates
Toni C. Denner, Niels V. Heise, Julian Zacharias, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1009-1009
Open Access | Times Cited: 8
Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations
Giulia Arrighi, Adrián Puerta, Andrea Petrini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7685-7685
Open Access | Times Cited: 12
Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment
Mahmoud F. Abo-Ashour, Hadia Almahli, Alessandro Bonardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2256-2264
Open Access | Times Cited: 10
Acipimox inhibits human carbonic anhydrases
Mattia Mori, Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 672-679
Open Access | Times Cited: 10
5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery
Stanislav Kalinin, Alexander Kovalenko, Annika Valtari, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1005-1011
Open Access | Times Cited: 10
Click chemistry‐based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors
Ewies F. Ewies, Eman Sabry, Mohamed S. Bekheit, et al.
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1281-1291
Closed Access | Times Cited: 10
Carbonic anhydrases
Claudiu T. Supuran
Elsevier eBooks (2023), pp. 139-156
Closed Access | Times Cited: 5
Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite Gyrodactylus salaris
Ashok Aspatwar, Alessandro Bonardi, Heidi Aisala, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Synthesis of new class of non-sulfonamide bis-benzimidazoles as antitumor agents by inhibiting carbonic anhydrase-IX enzyme
Shakeel Ahmad Khan, Zarbad Shah, Syed Raza Shah, et al.
International Journal of Biological Macromolecules (2023) Vol. 255, pp. 128259-128259
Closed Access | Times Cited: 4
Lupane acetates in small molecule drug hybrids: Probing their inhibitory activity for carbonic anhydrase II
Toni C. Denner, Niels V. Heise, Julian Zacharias, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 10, pp. 100139-100139
Open Access | Times Cited: 1
Exploring Natural Product Derivatives having Carbonic Anhydrase Inhibitory Activity
Shakthi Devi Packiapalavesam, Venkatesan Saravanan, Pavithra Ramesh, et al.
Journal of Natural Remedies (2024), pp. 953-971
Open Access | Times Cited: 1
Synthesis, Antibacterial, and Antimonooxidase Activity of 4-(2-Methyl-1,3-oxazol-5-yl)benzenesulfonamide
O. A. Gasilina, A. A. Romanycheva, Антон А. Шетнев, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 11, pp. 2749-2755
Closed Access | Times Cited: 3
Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials
Na‐Chuan Luo, Xun Jiang, Meiqi Hao, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 5
Highlighting the Issues Associated with Glaucoma Medication Therapy: A Pharmaceutical Care Evaluation
Hozan Jaza Hama Salh, Tara Ahmed Hussein, Tavga Ahmed Aziz
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2023) Vol. 5, pp. 57-66
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top